NYSE:ADCT | Balance Sheet | ADC Therapeutics SA

Complete source-backed balance-sheet history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$219.11M$4.93M$4.25M$261.71M$1.24M$279.38M$12.76M$86.33M$6.17M$507.58M-$228.21M
2026-03-31$231.01M$4.78M$4.27M$276.77M$1.25M$291.5M$5.3M$67.63M$5M$507.87M-$216.38M
2025-12-31$261.34M$4.18M$6.08M$306.34M$0.00$1.22M$323.15M$9.18M$70.16M$2.81M$508.98M-$185.83M
2025-09-30$234.74M$18.04M$5.52M$287.15M$0.00$1.22M$289.76M$8.12M$62.04M$9.39M$527.94M-$238.18M
2025-06-30$264.56M$17.76M$5.66M$318.76M$1,000.00$1.32M$321.56M$9.62M$64.6M$7.17M$520.75M-$199.18M
2025-03-31$194.7M$17.45M$7.18M$257.99M$5.16M$1.16M$272.54M$15.59M$57.79M$4.45M$510.76M-$238.22M
2024-12-31$250.87M$2.25M$9.45M$291.25M$5.08M$1.16M$321.98M$18.03M$80.47M$2.43M$524.62M-$202.64M
2024-09-30$274.27M$16.07M$333.01M$5.72M$1.17M$349.08M$14.37M$67.68M$7.65M$521.03M-$171.95M
2024-06-30$300.12M$15.19M$355.36M$5.48M$992,000.00$371.78M$10.71M$57.63M$6.62M$503.45M-$131.67M
2024-03-31$234.29M$16M$290.21M$5.79M$986,000.00$307.97M$14.32M$62.99M$6.52M$502.42M-$194.45M
2023-12-31$278.6M$16.18M$5.99M$336.29M$5.62M$711,000.00$354.78M$15.57M$67.67M$8.88M$503.03M-$148.25M
2023-09-30$310.41M-$64.25M
2023-06-30$347.51M-$19.7M
2023-03-31$310.55M$28.42M
2022-12-31$326.44M$12.07M$434.98M$3.36M$902,000.00$490.86M$12.35M$81.94M$838,000.00$411.41M$79.45M
2021-12-31$466.54M$154.03M